Short wavelength automated perimetry

Acta Ophthalmologica Scandinavica

Volumn 79, Issue 6, 2001, Pages 546-559

  Wild, J M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Diabetes; Glaucoma; Ocular hypertension; Perimetry; Short wavelength sensitive; SWAP; Visual fields

Indexed keywords

ABSORPTION; ADULT; COHORT ANALYSIS; COLOR VISION; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERMETHOD COMPARISON; LEARNING; LUMINANCE; NERVE MALFORMATION; NEUROOPHTHALMOLOGY; OPTIC NERVE; PERIMETRY; PRIORITY JOURNAL; RETINA CONE; RETINA MACULA EDEMA; RETINA NERVE CELL; RETINA ROD; REVIEW; SPECTRAL SENSITIVITY; SYNDROME DELINEATION; TECHNIQUE; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

GLAUCOMA; HUMANS; MACULAR EDEMA, CYSTOID; NERVE FIBERS; NERVOUS SYSTEM DISEASES; OPTIC DISK; PERIMETRY; RETINA; VISION DISORDERS; VISUAL FIELDS;

EID: 0035211172     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2001.790602.x     Document Type: Review

References (126)

1. Macular oedema reduces B cone sensitivity in diabetics
2. S-cone pathway sensitivity loss in ocular hypertension and early glaucoma has nerve fibre bundle pattern
3. Glaucoma hemifield test
4. Diffuse visual field loss and glaucoma
5. Physiology of cumulative defect curves; consequences in glaucoma perimetry
6. The effect of age on the optic nerve fiber population in the human optic nerve
7. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population
8. The cumulative deficit curve: Separation of local and diffuse components of visual field damage
9. Static perimetry: Accuracy and fluctuations
10. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract
11. Comparison of long-term variability for standard and short-wavelength automated perimetry in stable glaucoma patients
12. Analysis of the macular pigment by HPLC: Retinal distribution and age study
13. Should we use short-wavelength automated perimetry to test glaucoma patients
14. Longitudinal comparison of temporal-modulation perimetry with white-on-white and blue-on-yellow perimetry in ocular hypertension and early glaucoma
15. A cluster analysis for threshold perimetry
16. The use of visual field indices in detecting changes in the visual field in glaucoma
17. Repeatable diffuse visual field loss in open-angle glaucoma
18. Aging of the human crystalline lens and anterior segment
19. Morphology of a small bistratified ganglion cell type in the macaque and human retina
20. The 'blue-on' opponent pathway in primate retina originates from a distinct ganglion cell type
21. Blue-yellow perimetry in the detection of early glaucomatous damage
22. Fundus reflectance and the measurement of crystalline lens density
23. Isolation of short-wavelength sensitive mechanisms in normal and glaucomatous visual field regions
24. Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients
25. Neuron loss in the aging visual cortex of man
26. Ageing of the optic nerve
27. Distribution patterns of photoreceptors, protein and cyclic nucleotides in the human retina
28. Functional characteristics of blue-on-yellow perimetric thresholds in glaucoma
29. Differential light threshold in automated static perimetry - Factors influencing short-term fluctuation
30. Covariates of the long-term fluctuation of the differential light threshold
31. Evaluation of FASTPAC: A new strategy for threshold estimation with the Humphrey Field Analyzer
32. Use of blue-on-yellow perimetry to demonstrate quadrantanopia in multiple sclerosis
33. Aging and degeneration of the human macula: 1. Outer nuclear layer and photoreceptors
34. Deficits in perimetric performance in patients with symptomatic human immunodeficiency virus infection or acquired immunodeficiency syndrome
35. Short wavelength automated perimetry and standard perimetry in the detection of progressive optic disc cupping
36. S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma
37. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy
38. Action spectrum for retinal injury from near UV radiation in aphakic monkey
39. Macular pigment optical density in a Southwestern sample
40. Multivariate analysis of the risk of glaucomatous visual field loss
41. Time changes of contrast thresholds during automated perimetry
42. Normal variability of static perimetric threshold values across the central field
43. The effect of perimetric experience in normal subjects
44. Visual field interpretation with empirical probability maps
45. The effect of perimetric experience in patients with glaucoma
46. Central visual fields for short wavelength sensitive pathways in glaucoma and ocular hypertension
47. Maximizing the dynamic range of the Humphrey Field Analyzer for blue-on-yellow perimetry
48. Fatigue effects during a single session of automated static threshold perimetry in normals and ocular hypertensives
49. Short-wavelength sensitive field loss in patients with clinically significant diabetic macular oedema
50. Influence of laser photocoagulation for clinically significant diabetic macular oedema (DMO) on short-wavelength and conventional automated perimetry
51. The long-term fluctuation of the visual field in stable glaucoma
52. Long-term fluctuation in short-wavelength automated perimetry in glaucoma suspects and glaucoma patients
53. Age-related changes in the central visual field for short-wavelength sensitive pathways
54. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results
55. Fatigue effects in automated perimetry
56. Evidence for a neural basis of age-related visual field loss in normal observers
57. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss
58. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry
59. A noninvasive video-based method of measuring lens transmission properties of the human eye
60. Selective vs nonselective losses in glaucoma
61. Early losses of visual function in glaucoma
62. Aging effects for opponent mechanisms in the central visual field
63. Short-wave-length automated perimetry in neuro-ophthalmologic disorders
64. Foveal cone pigment density differences in the aging human eye
65. Luminance and opponent-color contributions to visual detection and adaptation and to temporal and spatial integration
66. Comparative study between point-wise and ranked threshold distribution analyses of change in serial fields for short-wavelength automated perimetry
67. Factors associated with a learning effect in glaucoma patients using automated perimetry
68. Test-retest variability of blue-on-yellow perimetry is greater than white-on-white perimetry in normal subjects
69. Population study of global and local fatigue within prolonged threshold testing in automated perimetry
70. Lenses of patients with diabetes yellow at an accelerated rate similar to older normals
71. Lens-corrected visual field sensitivity and diabetes
72. Achromatic and short-wavelength automated perimetry in patients with glaucomatous large cups
73. Evidence that blue-on cells are part of the third geniculo-cortical pathway in primates
74. Retinal ganglion cell death in experimental glaucoma
75. The influence of age-related cataract on blue-on-yellow perimetry
76. The influence of induced forward light scatter on the normal blue-on-yellow perimetric profile
77. Blue-on-yellow perimetry to evaluate S cone sensitivity in diabetics
78. Optical density of human macular pigment
79. Visual field loss in HIV-positive patients without infectious retinopathy
80. Short-wavelength automated perimetry and retinal nerve fibre layer evaluation in suspected cases of glaucoma
81. Correlation of functional and structural measurements in eyes suspected of having glaucoma
82. Functional and structural measurements in a multifactorial glaucoma risk model
83. Chronic glaucoma selectively damages large optic nerve fibres
84. Chronic human glaucoma causing selectively greater loss of large optic nerve fibres
85. Short-wavelength automated perimetry and capillary density in early diabetic maculopathy
86. A practical method for obtaining an index of lens density with an automated perimeter
87. The ageing lens: In vivo assessment of light absorption in 84 human eyes
88. Color perimetry for assessment of primary open-angle glaucoma
89. Progressive color vision loss in glaucoma
90. Variability and sensitivity of short-wavelength color visual fields in normal and glaucoma eyes
91. Short wavelength colour visual fields in glaucoma suspects at risk
92. Short wavelength automated perimetry without lens density testing
93. Optimum parameters for short-wavelength automated perimetry
94. Asymmetries in the normal visual field: Implications for short wavelength automated perimetry
95. Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma
96. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma
97. Age changes in the optical density of human ocular media
98. Sites of age-related sensitivity loss in a short-wave cone pathway
99. Progressive dendritic changes in aging human cortex
100. Time-related variation in normal automated static perimetry
101. Blue-yellow perimetry in patients with ocular hypertone
102. Lens autofluorescence in healthy individuals
103. Autofluorescence in cataractous human lens and its relationship to light scatter
104. The directional sensitivity of the retina and the spectral sensitivities of the rods and cones
105. Colour Vision: The approach through increment-threshold sensitivity
106. Fluorometry of the crystalline lens for correcting blue-on-yellow perimetry results
107. Correlation of blue-on-yellow visual fields with scanning confocal laser optic disc measurements
108. Hemifield association between blue-on-yellow visual field and optic nerve head topographic measurements
109. Blue-on-yellow visual field and retinal nerve fibre layer in ocular hypertension and glaucoma
110. Relationship between structural abnormalities and short-wavelength perimetric defects in eyes at risk of glaucoma
111. Spectral Transmission of the human ocular media
112. Density of human cone photopigments as a function of age
113. Effect of patient experience on the results of automated perimetry in glaucoma suspect patients
114. Development of scotopic sensitivity and the absorption spectrum of the human ocular media
115. The statistical interpretation of blue-on-yellow visual field loss
116. Baseline alterations in blue-on-yellow normal perimetric sensitivity
117. Statistical aspects of the normal visual field in short-wavelength automated perimetry
118. The influence of the learning effect on automated perimetry in patients with suspected glaucoma
119. Long-term follow-up of baseline learning and fatigue effects in the automated perimetry of glaucoma and ocular hypertensive patients
120. The attenuation of blue-on-yellow perimetry by the macular pigment
121. Visual fatigue during prolonged visual field testing in optic neuropathies
122. Serial examination of the normal visual field using Octopus automated projection perimetry: Evidence for a learning effect
123. Mapping structural damage of the optic disk to visual field defect in glaucoma
124. The effect of background luminance on cone sensitivity functions
125. Evaluation of an objective method for the in vivo measurement of changes in light transmittance of the human crystalline lens
126. Spectral sensitivity measurements in early diabetic retinopathy